Funded Health Care Startups in Sweden
Across these 47 Sweden-based health care funding entries, the largest disclosed round is Raysearch Laboratories’ $50M on 2025-03-18; it sits well above the…
Across these 47 Sweden-based health care funding entries, the largest disclosed round is Raysearch Laboratories’ $50M on 2025-03-18; it sits well above the next-largest disclosed amounts (e.g., $49M for Occlutech on 2021-12-21 and $48M for Doctor24 on 2021-05-20), while many other disclosed rounds cluster in the low single-digit millions (for example $2M–$5M appears repeatedly in 2026). The date range spans from 2026-06-10 (Celluminova) back to 2020-06-01 (Doctrin), with multiple entries concentrated in early-to-mid 2026 (e.g., May–June 2026 includes IRLAB Therapeutics $11M on 2026-05-05, and $3M on 2026-06-05 for Klaria Pharma Holding). A geography/stage pattern also stands out: Stockholm and Lund recur frequently, and “Series Unknown” dominates—appearing in 34 of 47 rows—alongside a smaller set of explicitly labeled rounds such as Seed, Series A, and Angel.
Most recent rounds
47 shownRelated listings
Frequently asked
What’s the biggest disclosed round in this Sweden health care list, and how far above the rest is it?
Raysearch Laboratories’ $50M (2025-03-18) is the largest disclosed amount. It is followed by other high outliers like Occlutech’s $49M (2021-12-21) and Doctor24’s $48M (2021-05-20), while many other disclosed rounds are in the $2M–$13M range.
Do the most recent entries cluster in time, or are dates evenly spread across the window?
They cluster toward the top of the window: early-to-mid 2026 contains multiple funded rounds, including IRLAB Therapeutics $11M (2026-05-05), Klaria Pharma Holding $3M (2026-06-05), and Celluminova $2M (2026-06-10). The list also extends back to 2020-06-01 (Doctrin), indicating substantial temporal spread rather than a single tight burst.
Which cities show up most often, and does that suggest a geographic hub pattern?
Stockholm-based companies recur repeatedly (e.g., Klaria Pharma Holding in Uppsala, but also Loovi $1M on 2026-02-12, AlzeCure Pharma on 2026-04-24 at $3M, and Doctor24 in Stockholm on 2021-05-20 at $48M). Lund and Gothenburg also appear often (e.g., ChemoTech $640K on 2026-06-02 in Lund; Observe Medical $2M on 2026-03-04 in Gothenburg), suggesting multiple regional hubs rather than one city only.
How dominant is ‘Series Unknown’ versus specified stages in this dataset?
“Series Unknown” accounts for 34 of 47 rows. Explicit labels are present but less frequent—for instance, Seed appears at least at Adsorbi $1M (2025-01-28), Corsmed $4M (2024-12-18), and Meela $3M (2024-07-01), while Series A shows up in entries like Neko Health $65M (2023-07-05) and Raysearch Labs $50M is labeled as Series Unknown.
Are there very small disclosed rounds that act as lows or ‘floor’ signals compared with the rest?
The smallest disclosed amount is MucoLife Therapeutics’ $30K (2024-09-06). That minimum is far below the rest of the disclosed range—for example, many disclosed rounds in 2026 sit at $520K and above (ChemoTech $640K; Spermosens $520K; Blodtrycksdoktorn $760K).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.